European Surveillance of Antimicrobial Consumption (ESAC): Outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009)

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue SUPPL. 6, 2011, Pages

  Adriaenssens, Niels ^a   Coenen, Samuel ^a   Versporten, Ann ^a   Muller, Arno ^a   Minalu, Girma ^b   Faes, Christel ^b   Vankerckhoven, Vanessa ^a   Aerts, Marc ^b   Hens, Niel ^a,b   Molenberghs, Geert ^b,c   Goossens, Herman ^a   Metz, Sigrid ^d   Fluch, Gerhard ^d   Vaerenberg, Sofie ^d   Goossens, Mathijs Michiel ^d   Markova, Boyka ^d   Andrašević, Arjana Tambic ^d   Kontemeniotis, Antonis ^d   Vlček, Jiří ^d   Frimodt Møller, Niels ^d   Jensen, Ulrich Stab ^d   Rootslane, Ly ^d   Laius, Ott ^d   Vuopio Varkila, Jaana ^d   Lyytikainen, Outi ^d   Cavalie, Philippe ^d   Kern, Winfried ^d   Giamarellou, Helen ^d   Antoniadou, Anastasia ^d   Ternák, Gábor ^d   Benko, Ria ^d   Briem, Haraldur ^d   Einarsson, Olafur ^d   Cunney, Robert ^d   Oza, Ajay ^d   Raz, Raul ^d   Edelstein, Hana ^d   Folino, Pietro ^d   Seilis, Andis ^d   Dumpis, Uga ^d   Valinteliene, Rolanda ^d   Bruch, Marcel ^d   Borg, Michael ^d   Zarb, Peter ^d   Natsch, Stephanie ^d   Kwint, Marieke ^d   Blix, Hege Salvesen ^d   Hryniewics, Waleria ^d   Olczak Pienkowska, Anna ^d   Kravanja, Malgorzata ^d   Ozorowski, Tomasz ^d   Ribeirinho, Mafalda ^d   Caldeira, Luis ^d   Bǎicuş, Anda ^d   Popescu, Gabriel ^d   Ratchina, Svetlana ^d   Kozlov, Roman ^d   Foltán, Viliam ^d   Čižman, Milan ^d   Lázaro, Edurne ^d   Campos, José ^d   de Abajo, Francisco ^d   Dohnhammar, Ulrica ^d   Zanetti, Giorgio ^d   Davey, Peter ^d   Wickens, Hayley ^d   more..

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c KU LEUVEN   (Belgium)

^d NONE

Author keywords

Ambulatory care; Antibiotic use; Drug consumption; Pharmacoepidemiology

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; PRISTINAMYCIN; ROXITHROMYCIN; STREPTOGRAMIN;

ARTICLE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG USE; EUROPE; FRANCE; GREECE; HUMAN; LONGITUDINAL STUDY; OUTPATIENT CARE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; SWEDEN; TREND STUDY;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; EUROPE; HALF-LIFE; HUMANS; LINCOSAMIDES; MACROLIDES; OUTPATIENTS; PHARMACOEPIDEMIOLOGY; SEASONS; STATISTICS AS TOPIC; STREPTOGRAMINS;

EID: 82055196786     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr456     Document Type: Article

References (11)

1. Coenen S, Ferech M, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 2006; 58: 418-22.
2. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi3-12.
3. Minalu G, Aerts M, Coenen S et al. Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis. J Antimicrob Chemother 2011; 66 Suppl 6: vi79-87.
4. Faes C, Molenberghs G, Hens N et al. Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis. J Antimicrob Chemother 2011; 66 Suppl 6: vi89-94.
5. Versporten A, Coenen S, Adriaenssens N et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi13-23.
6. European Medicines Agency. EMEA Statement on the Safety of Ketek (Telithromycin). London: European Medicines Agency Press Office, 2006. www.ema.europa.eu/docs/en_GB/document_library/Press_release/2009/11/WC500015092.pdf (26 October 2011, date last accessed).
7. European Medicines Agency. European Medicines Agency Recommends Restricted Use and Strengthened Warnings for Ketek. London: European Medicines Agency Press Office, 2007. www.cbg-meb.nl/NR/rdonlyres/A26FE3CD-D737-414E-A0FE-5A23E6B5046E/0/20070405EMeApersbericht. pdf (26 October 2011, date last accessed).
8. Dyer C. European court rules that NHS incentive schemes for cheap prescribing do not breach law. BMJ 2010; 340: c2232.
9. Friis H, Bro F, Eriksen NR et al. The effect of reimbursement on the use of antibiotics. Scand J Prim Health Care 1993; 11: 247-51.
10. The Swedish Strategic Programme Against Antibiotic Resistance (STRAMA). Treating Infections in Primary Care-Clinical Guidelines. South West Skåne: STRAMA, 2000. http://soapimg.icecube.snowfall.se/strama/Skane_vardprogr_engelsk_version.pdf (26 October 2011, date last accessed).
11. Malhotra-Kumar S, Lammens C, Coenen S et al. Impact of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci among healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007; 369: 482-90.